Beta Bionics (BBNX) Stock: Buy, Sell, or Hold?
BBNX - Beta Bionics, Inc. Common Stock
$16.57
-0.02 (-0.12%)
▼
5d:
-16.82%
30d:
-4.39%
90d:
+12.8%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When BBNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BBNX is down 16.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BBNX is down 16.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BBNX is currently trading at $16.57, which is considered slightly low relative to its 30-day fair value range of $16.27 to $19.87.
Technical Outlook: Technically, BBNX is in a strong uptrend. Immediate support is located at $15.85, while resistance sits at $20.23.
Market Sentiment: BBNX scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.31 (+22.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BBNX is in a strong uptrend. Immediate support is located at $15.85, while resistance sits at $20.23.
Market Sentiment: BBNX scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.31 (+22.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$16.27 -
$19.87
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (19/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.6% below Wall St target ($20.31)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.27 -
$19.87
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$2.53
(15.3%)
Support & Resistance Levels
Support Level
$15.85
Resistance Level
$20.23
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.16
Wall Street Target
$20.31
(+22.6%)
Revenue Growth (YoY)
37.8%
Profit Margin
-61.3%
Share & Embed Analysis
Last updated: September 12, 2026 2:35 PM ET
Data refreshes hourly during market hours. Next update: 3:35 PM
Data refreshes hourly during market hours. Next update: 3:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
